Click here to access week 7 of the Kitsap Respiratory Illness Report: 02.12.23-02.18.23. Summary: Local influenza activity is currently low, with 9 positive influenza tests in the past week (1,689 cumulative (18.2% of total tested) since 10/2/2022). RSV activity is currently low, with 4 positive RSV tests in the past week (488 since the start of … Kitsap Respiratory Illness Report: February 12 – February 18
Click here to access week 6 of the Kitsap Respiratory Illness Report: 02.05.23-02.11.23. Summary: Local influenza activity is currently low, with 5 positive influenza tests in the past week (1,680 cumulative (18.9% of total tested) since 10/2/2022). RSV activity is currently low, with 2 positive RSV tests in the past week (484 since the start of … Kitsap Respiratory Illness Report: February 5 – February 11
Click here to access week 4 of the Kitsap Respiratory Illness Report: 01.29.23-02.04.23. Summary: Local influenza activity is currently low, with 4 positive influenza tests in the past week (1,675 cumulative (19.7% of total tested) since 10/2/2022). RSV activity is currently elevated, with 6 positive RSV tests in the past week (482 since the start of … Kitsap Respiratory Illness Report: January 29 – February 4
Click here to access week 4 of the Kitsap Respiratory Illness Report: 01.22.2023 – 01.28.2023. Summary: Local influenza activity is currently low, with 2 positive influenza tests in the past week (1,671 cumulative (20.6% of total tested) since 10/2/2022). RSV activity is currently elevated, with 5 positive RSV tests in the past week (476 since the … Kitsap Respiratory Illness Report: January 22 – January 28
On January 26, 2023, the Food and Drug Administration (FDA) announced that Evusheld (tixagevimab co-packaged with cilgavimab) is not currently authorized for use in the U.S. Facilities and providers should continue to store Evusheld in the event that variants susceptible to Evusheld become more prevalent. Evusheld Effectiveness Evusheld is unlikely to be active against SARS-CoV-2 variants projected … Evusheld no longer authorized for COVID-19 prevention
